Search

Author/Creator Germani, Marco M.

1. Exploring clinical and gene expression markers of benefit from FOLFOXIRI/bevacizumab in patients with BRAF-mutated metastatic colorectal cancer: Subgroup analyses of the TRIBE2 study. (August 2021)

Authors:
Moretto, Roberto; Giordano, Mirella; Poma, Anello M.; Passardi, Alessandro; Boccaccino, Alessandra; Pietrantonio, Filippo; Tomasello, Gianluca; Aprile, Giuseppe; Lonardi, Sara; Conca, Veronica; Granetto, Cristina; Frassoldati, Antonio; Clavarezza, Matteo; Bertolini, Alessandro S.; Germani, Marco ...
Journal:
European journal of cancer
Issue:
Volume 153(2021)
Page Start:
16
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. FOLFOXIRI and bevacizumab in patients with early-onset metastatic colorectal cancer. A pooled analysis of TRIBE and TRIBE2 studies. (May 2022)

Authors:
Antoniotti, Carlotta; Germani, Marco M.; Rossini, Daniele; Lonardi, Sara; Pietrantonio, Filippo; Santini, Daniele; Marmorino, Federica; Allegrini, Giacomo; Daniel, Francesca; Raimondi, Alessandra; Borelli, Beatrice; Zaniboni, Alberto; Conca, Veronica; Abraham, Jim; Spetzler, David; Maiello, Evari...
Journal:
European journal of cancer
Issue:
Volume 167(2022)
Page Start:
23
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Treatments after second progression in metastatic colorectal cancer: A pooled analysis of the TRIBE and TRIBE2 studies. (July 2022)

Authors:
Rossini, Daniele; Germani, Marco M.; Lonardi, Sara; Pietrantonio, Filippo; Dell'Aquila, Emanuela; Borelli, Beatrice; Allegrini, Giacomo; Maddalena, Giulia; Randon, Giovanni; Marmorino, Federica; Zaniboni, Alberto; Buonadonna, Angela; Boccaccino, Alessandra; Conca, Veronica; Antoniotti, Carlotta; ...
Journal:
European journal of cancer
Issue:
Volume 170(2022)
Page Start:
64
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search